Glutamate Receptors in the Central Nucleus of the Amygdala Mediate Cisplatin-Induced Malaise and Energy Balance Dysregulation through Direct Hindbrain Projections.
Amber L AlhadeffRuby A HollandAlexandra NelsonHarvey J GrillBart C De JonghePublished in: The Journal of neuroscience : the official journal of the Society for Neuroscience (2015)
To treat cancer effectively, patients must follow prescribed chemotherapy treatments without interruption, yet most cancer treatments produce side effects that devastate quality of life (e.g., nausea, vomiting, anorexia, weight loss). Although hundreds of thousands of patients undergo chemotherapies each year, the neural mechanisms mediating their side effects are unknown. The current data outline a neural circuit activated by cisplatin chemotherapy and demonstrate that glutamate signaling in the amygdala, arising from hindbrain projections, is required for the full expression of cisplatin-induced malaise, anorexia, and body weight loss. Together, these data help to characterize the neural circuits and neurotransmitters mediating chemotherapy-induced energy balance dysregulation, which will ultimately provide an opportunity for the development of well tolerated cancer and anti-emetic treatments.
Keyphrases
- chemotherapy induced
- weight loss
- end stage renal disease
- papillary thyroid
- ejection fraction
- chronic kidney disease
- newly diagnosed
- bariatric surgery
- prognostic factors
- poor prognosis
- functional connectivity
- peritoneal dialysis
- squamous cell carcinoma
- type diabetes
- electronic health record
- big data
- artificial intelligence
- weight gain
- gastric bypass
- long non coding rna
- skeletal muscle